Genital herpes is a sexually transmitted disease (STD). This STD causes herpetic sores, which are painful blisters (fluid-filled bumps) that can break open and ooze fluid. About 16 percentTrusted Source of people between the ages of 14 and 49 have this STD.

The global Genital Herpes Treatment Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Genital Herpes Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genital Herpes Treatment Drugs.

Report Scope

The Genital Herpes Treatment Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Genital Herpes Treatment Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Genital Herpes Treatment Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Genital Herpes Treatment Drugs Market Report

Report Metric	Details
Report Name	Genital Herpes Treatment Drugs Market
CAGR	5%
Segment by Type	Acyclovir Famciclovir Valacyclovir
Segment by Application	Hospitals Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AstraZeneca, Plc., Apotheca, Inc., Asahi Kasei Pharma Corporation, Carlsbad Technology, Inc., GlaxoSmithkline, Plc., Mylan N.V., Novartis AG., Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Zydus Pharmaceuticals, Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genital Herpes Treatment Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Genital Herpes Treatment Drugs Market report?

Ans: The main players in the Genital Herpes Treatment Drugs Market are AstraZeneca, Plc., Apotheca, Inc., Asahi Kasei Pharma Corporation, Carlsbad Technology, Inc., GlaxoSmithkline, Plc., Mylan N.V., Novartis AG., Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Zydus Pharmaceuticals, Inc.

What are the Application segmentation covered in the Genital Herpes Treatment Drugs Market report?

Ans: The Applications covered in the Genital Herpes Treatment Drugs Market report are Hospitals, Clinic, Others

What are the Type segmentation covered in the Genital Herpes Treatment Drugs Market report?

Ans: The Types covered in the Genital Herpes Treatment Drugs Market report are Acyclovir, Famciclovir, Valacyclovir

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Genital Herpes Treatment Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Acyclovir

1.2.3 Famciclovir

1.2.4 Valacyclovir

1.3 Market by Application

1.3.1 Global Genital Herpes Treatment Drugs Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinic

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Genital Herpes Treatment Drugs Market Perspective (2019-2030)

2.2 Genital Herpes Treatment Drugs Growth Trends by Region

2.2.1 Global Genital Herpes Treatment Drugs Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Genital Herpes Treatment Drugs Historic Market Size by Region (2019-2024)

2.2.3 Genital Herpes Treatment Drugs Forecasted Market Size by Region (2025-2030)

2.3 Genital Herpes Treatment Drugs Market Dynamics

2.3.1 Genital Herpes Treatment Drugs Industry Trends

2.3.2 Genital Herpes Treatment Drugs Market Drivers

2.3.3 Genital Herpes Treatment Drugs Market Challenges

2.3.4 Genital Herpes Treatment Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Genital Herpes Treatment Drugs Players by Revenue

3.1.1 Global Top Genital Herpes Treatment Drugs Players by Revenue (2019-2024)

3.1.2 Global Genital Herpes Treatment Drugs Revenue Market Share by Players (2019-2024)

3.2 Global Genital Herpes Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Genital Herpes Treatment Drugs Revenue

3.4 Global Genital Herpes Treatment Drugs Market Concentration Ratio

3.4.1 Global Genital Herpes Treatment Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Genital Herpes Treatment Drugs Revenue in 2023

3.5 Genital Herpes Treatment Drugs Key Players Head office and Area Served

3.6 Key Players Genital Herpes Treatment Drugs Product Solution and Service

3.7 Date of Enter into Genital Herpes Treatment Drugs Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Genital Herpes Treatment Drugs Breakdown Data by Type

4.1 Global Genital Herpes Treatment Drugs Historic Market Size by Type (2019-2024)

4.2 Global Genital Herpes Treatment Drugs Forecasted Market Size by Type (2025-2030)

5 Genital Herpes Treatment Drugs Breakdown Data by Application

5.1 Global Genital Herpes Treatment Drugs Historic Market Size by Application (2019-2024)

5.2 Global Genital Herpes Treatment Drugs Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Genital Herpes Treatment Drugs Market Size (2019-2030)

6.2 North America Genital Herpes Treatment Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Genital Herpes Treatment Drugs Market Size by Country (2019-2024)

6.4 North America Genital Herpes Treatment Drugs Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Genital Herpes Treatment Drugs Market Size (2019-2030)

7.2 Europe Genital Herpes Treatment Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Genital Herpes Treatment Drugs Market Size by Country (2019-2024)

7.4 Europe Genital Herpes Treatment Drugs Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Genital Herpes Treatment Drugs Market Size (2019-2030)

8.2 Asia-Pacific Genital Herpes Treatment Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Genital Herpes Treatment Drugs Market Size by Region (2019-2024)

8.4 Asia-Pacific Genital Herpes Treatment Drugs Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Genital Herpes Treatment Drugs Market Size (2019-2030)

9.2 Latin America Genital Herpes Treatment Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Genital Herpes Treatment Drugs Market Size by Country (2019-2024)

9.4 Latin America Genital Herpes Treatment Drugs Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Genital Herpes Treatment Drugs Market Size (2019-2030)

10.2 Middle East & Africa Genital Herpes Treatment Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Genital Herpes Treatment Drugs Market Size by Country (2019-2024)

10.4 Middle East & Africa Genital Herpes Treatment Drugs Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AstraZeneca, Plc.

11.1.1 AstraZeneca, Plc. Company Detail

11.1.2 AstraZeneca, Plc. Business Overview

11.1.3 AstraZeneca, Plc. Genital Herpes Treatment Drugs Introduction

11.1.4 AstraZeneca, Plc. Revenue in Genital Herpes Treatment Drugs Business (2019-2024)

11.1.5 AstraZeneca, Plc. Recent Development

11.2 Apotheca, Inc.

11.2.1 Apotheca, Inc. Company Detail

11.2.2 Apotheca, Inc. Business Overview

11.2.3 Apotheca, Inc. Genital Herpes Treatment Drugs Introduction

11.2.4 Apotheca, Inc. Revenue in Genital Herpes Treatment Drugs Business (2019-2024)

11.2.5 Apotheca, Inc. Recent Development

11.3 Asahi Kasei Pharma Corporation

11.3.1 Asahi Kasei Pharma Corporation Company Detail

11.3.2 Asahi Kasei Pharma Corporation Business Overview

11.3.3 Asahi Kasei Pharma Corporation Genital Herpes Treatment Drugs Introduction

11.3.4 Asahi Kasei Pharma Corporation Revenue in Genital Herpes Treatment Drugs Business (2019-2024)

11.3.5 Asahi Kasei Pharma Corporation Recent Development

11.4 Carlsbad Technology, Inc.

11.4.1 Carlsbad Technology, Inc. Company Detail

11.4.2 Carlsbad Technology, Inc. Business Overview

11.4.3 Carlsbad Technology, Inc. Genital Herpes Treatment Drugs Introduction

11.4.4 Carlsbad Technology, Inc. Revenue in Genital Herpes Treatment Drugs Business (2019-2024)

11.4.5 Carlsbad Technology, Inc. Recent Development

11.5 GlaxoSmithkline, Plc.

11.5.1 GlaxoSmithkline, Plc. Company Detail

11.5.2 GlaxoSmithkline, Plc. Business Overview

11.5.3 GlaxoSmithkline, Plc. Genital Herpes Treatment Drugs Introduction

11.5.4 GlaxoSmithkline, Plc. Revenue in Genital Herpes Treatment Drugs Business (2019-2024)

11.5.5 GlaxoSmithkline, Plc. Recent Development

11.6 Mylan N.V.

11.6.1 Mylan N.V. Company Detail

11.6.2 Mylan N.V. Business Overview

11.6.3 Mylan N.V. Genital Herpes Treatment Drugs Introduction

11.6.4 Mylan N.V. Revenue in Genital Herpes Treatment Drugs Business (2019-2024)

11.6.5 Mylan N.V. Recent Development

11.7 Novartis AG.

11.7.1 Novartis AG. Company Detail

11.7.2 Novartis AG. Business Overview

11.7.3 Novartis AG. Genital Herpes Treatment Drugs Introduction

11.7.4 Novartis AG. Revenue in Genital Herpes Treatment Drugs Business (2019-2024)

11.7.5 Novartis AG. Recent Development

11.8 Merck & Co., Inc.

11.8.1 Merck & Co., Inc. Company Detail

11.8.2 Merck & Co., Inc. Business Overview

11.8.3 Merck & Co., Inc. Genital Herpes Treatment Drugs Introduction

11.8.4 Merck & Co., Inc. Revenue in Genital Herpes Treatment Drugs Business (2019-2024)

11.8.5 Merck & Co., Inc. Recent Development

11.9 Teva Pharmaceutical Industries Ltd.

11.9.1 Teva Pharmaceutical Industries Ltd. Company Detail

11.9.2 Teva Pharmaceutical Industries Ltd. Business Overview

11.9.3 Teva Pharmaceutical Industries Ltd. Genital Herpes Treatment Drugs Introduction

11.9.4 Teva Pharmaceutical Industries Ltd. Revenue in Genital Herpes Treatment Drugs Business (2019-2024)

11.9.5 Teva Pharmaceutical Industries Ltd. Recent Development

11.10 Zydus Pharmaceuticals, Inc.

11.10.1 Zydus Pharmaceuticals, Inc. Company Detail

11.10.2 Zydus Pharmaceuticals, Inc. Business Overview

11.10.3 Zydus Pharmaceuticals, Inc. Genital Herpes Treatment Drugs Introduction

11.10.4 Zydus Pharmaceuticals, Inc. Revenue in Genital Herpes Treatment Drugs Business (2019-2024)

11.10.5 Zydus Pharmaceuticals, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Astrazeneca plc

Apotheca

Asahi Kasei Pharma Corporation

Carlsbad Technology, Inc.

Teva Pharmaceutical Industries Ltd

Zydus Pharmaceuticals, Inc.

List of Tables

Table 1. Global Genital Herpes Treatment Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Acyclovir

Table 3. Key Players of Famciclovir

Table 4. Key Players of Valacyclovir

Table 5. Global Genital Herpes Treatment Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Genital Herpes Treatment Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Genital Herpes Treatment Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Genital Herpes Treatment Drugs Market Share by Region (2019-2024)

Table 9. Global Genital Herpes Treatment Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Genital Herpes Treatment Drugs Market Share by Region (2025-2030)

Table 11. Genital Herpes Treatment Drugs Market Trends

Table 12. Genital Herpes Treatment Drugs Market Drivers

Table 13. Genital Herpes Treatment Drugs Market Challenges

Table 14. Genital Herpes Treatment Drugs Market Restraints

Table 15. Global Genital Herpes Treatment Drugs Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Genital Herpes Treatment Drugs Market Share by Players (2019-2024)

Table 17. Global Top Genital Herpes Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genital Herpes Treatment Drugs as of 2023)

Table 18. Ranking of Global Top Genital Herpes Treatment Drugs Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Genital Herpes Treatment Drugs Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Genital Herpes Treatment Drugs Product Solution and Service

Table 22. Date of Enter into Genital Herpes Treatment Drugs Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Genital Herpes Treatment Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Genital Herpes Treatment Drugs Revenue Market Share by Type (2019-2024)

Table 26. Global Genital Herpes Treatment Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Genital Herpes Treatment Drugs Revenue Market Share by Type (2025-2030)

Table 28. Global Genital Herpes Treatment Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Genital Herpes Treatment Drugs Revenue Market Share by Application (2019-2024)

Table 30. Global Genital Herpes Treatment Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Genital Herpes Treatment Drugs Revenue Market Share by Application (2025-2030)

Table 32. North America Genital Herpes Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Genital Herpes Treatment Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Genital Herpes Treatment Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Genital Herpes Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Genital Herpes Treatment Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Genital Herpes Treatment Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Genital Herpes Treatment Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Genital Herpes Treatment Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Genital Herpes Treatment Drugs Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Genital Herpes Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Genital Herpes Treatment Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Genital Herpes Treatment Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Genital Herpes Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Genital Herpes Treatment Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Genital Herpes Treatment Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 47. AstraZeneca, Plc. Company Detail

Table 48. AstraZeneca, Plc. Business Overview

Table 49. AstraZeneca, Plc. Genital Herpes Treatment Drugs Product

Table 50. AstraZeneca, Plc. Revenue in Genital Herpes Treatment Drugs Business (2019-2024) & (US$ Million)

Table 51. AstraZeneca, Plc. Recent Development

Table 52. Apotheca, Inc. Company Detail

Table 53. Apotheca, Inc. Business Overview

Table 54. Apotheca, Inc. Genital Herpes Treatment Drugs Product

Table 55. Apotheca, Inc. Revenue in Genital Herpes Treatment Drugs Business (2019-2024) & (US$ Million)

Table 56. Apotheca, Inc. Recent Development

Table 57. Asahi Kasei Pharma Corporation Company Detail

Table 58. Asahi Kasei Pharma Corporation Business Overview

Table 59. Asahi Kasei Pharma Corporation Genital Herpes Treatment Drugs Product

Table 60. Asahi Kasei Pharma Corporation Revenue in Genital Herpes Treatment Drugs Business (2019-2024) & (US$ Million)

Table 61. Asahi Kasei Pharma Corporation Recent Development

Table 62. Carlsbad Technology, Inc. Company Detail

Table 63. Carlsbad Technology, Inc. Business Overview

Table 64. Carlsbad Technology, Inc. Genital Herpes Treatment Drugs Product

Table 65. Carlsbad Technology, Inc. Revenue in Genital Herpes Treatment Drugs Business (2019-2024) & (US$ Million)

Table 66. Carlsbad Technology, Inc. Recent Development

Table 67. GlaxoSmithkline, Plc. Company Detail

Table 68. GlaxoSmithkline, Plc. Business Overview

Table 69. GlaxoSmithkline, Plc. Genital Herpes Treatment Drugs Product

Table 70. GlaxoSmithkline, Plc. Revenue in Genital Herpes Treatment Drugs Business (2019-2024) & (US$ Million)

Table 71. GlaxoSmithkline, Plc. Recent Development

Table 72. Mylan N.V. Company Detail

Table 73. Mylan N.V. Business Overview

Table 74. Mylan N.V. Genital Herpes Treatment Drugs Product

Table 75. Mylan N.V. Revenue in Genital Herpes Treatment Drugs Business (2019-2024) & (US$ Million)

Table 76. Mylan N.V. Recent Development

Table 77. Novartis AG. Company Detail

Table 78. Novartis AG. Business Overview

Table 79. Novartis AG. Genital Herpes Treatment Drugs Product

Table 80. Novartis AG. Revenue in Genital Herpes Treatment Drugs Business (2019-2024) & (US$ Million)

Table 81. Novartis AG. Recent Development

Table 82. Merck & Co., Inc. Company Detail

Table 83. Merck & Co., Inc. Business Overview

Table 84. Merck & Co., Inc. Genital Herpes Treatment Drugs Product

Table 85. Merck & Co., Inc. Revenue in Genital Herpes Treatment Drugs Business (2019-2024) & (US$ Million)

Table 86. Merck & Co., Inc. Recent Development

Table 87. Teva Pharmaceutical Industries Ltd. Company Detail

Table 88. Teva Pharmaceutical Industries Ltd. Business Overview

Table 89. Teva Pharmaceutical Industries Ltd. Genital Herpes Treatment Drugs Product

Table 90. Teva Pharmaceutical Industries Ltd. Revenue in Genital Herpes Treatment Drugs Business (2019-2024) & (US$ Million)

Table 91. Teva Pharmaceutical Industries Ltd. Recent Development

Table 92. Zydus Pharmaceuticals, Inc. Company Detail

Table 93. Zydus Pharmaceuticals, Inc. Business Overview

Table 94. Zydus Pharmaceuticals, Inc. Genital Herpes Treatment Drugs Product

Table 95. Zydus Pharmaceuticals, Inc. Revenue in Genital Herpes Treatment Drugs Business (2019-2024) & (US$ Million)

Table 96. Zydus Pharmaceuticals, Inc. Recent Development

Table 97. Research Programs/Design for This Report

Table 98. Key Data Information from Secondary Sources

Table 99. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Genital Herpes Treatment Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Genital Herpes Treatment Drugs Market Share by Type: 2023 VS 2030

Figure 3. Acyclovir Features

Figure 4. Famciclovir Features

Figure 5. Valacyclovir Features

Figure 6. Global Genital Herpes Treatment Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Genital Herpes Treatment Drugs Market Share by Application: 2023 VS 2030

Figure 8. Hospitals Case Studies

Figure 9. Clinic Case Studies

Figure 10. Others Case Studies

Figure 11. Genital Herpes Treatment Drugs Report Years Considered

Figure 12. Global Genital Herpes Treatment Drugs Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Genital Herpes Treatment Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Genital Herpes Treatment Drugs Market Share by Region: 2023 VS 2030

Figure 15. Global Genital Herpes Treatment Drugs Market Share by Players in 2023

Figure 16. Global Top Genital Herpes Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genital Herpes Treatment Drugs as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Genital Herpes Treatment Drugs Revenue in 2023

Figure 18. North America Genital Herpes Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Genital Herpes Treatment Drugs Market Share by Country (2019-2030)

Figure 20. United States Genital Herpes Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Genital Herpes Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Genital Herpes Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Genital Herpes Treatment Drugs Market Share by Country (2019-2030)

Figure 24. Germany Genital Herpes Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Genital Herpes Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Genital Herpes Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Genital Herpes Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Genital Herpes Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Genital Herpes Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Genital Herpes Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Genital Herpes Treatment Drugs Market Share by Region (2019-2030)

Figure 32. China Genital Herpes Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Genital Herpes Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Genital Herpes Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Genital Herpes Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Genital Herpes Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Genital Herpes Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Genital Herpes Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Genital Herpes Treatment Drugs Market Share by Country (2019-2030)

Figure 40. Mexico Genital Herpes Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Genital Herpes Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Genital Herpes Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Genital Herpes Treatment Drugs Market Share by Country (2019-2030)

Figure 44. Turkey Genital Herpes Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Genital Herpes Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. AstraZeneca, Plc. Revenue Growth Rate in Genital Herpes Treatment Drugs Business (2019-2024)

Figure 47. Apotheca, Inc. Revenue Growth Rate in Genital Herpes Treatment Drugs Business (2019-2024)

Figure 48. Asahi Kasei Pharma Corporation Revenue Growth Rate in Genital Herpes Treatment Drugs Business (2019-2024)

Figure 49. Carlsbad Technology, Inc. Revenue Growth Rate in Genital Herpes Treatment Drugs Business (2019-2024)

Figure 50. GlaxoSmithkline, Plc. Revenue Growth Rate in Genital Herpes Treatment Drugs Business (2019-2024)

Figure 51. Mylan N.V. Revenue Growth Rate in Genital Herpes Treatment Drugs Business (2019-2024)

Figure 52. Novartis AG. Revenue Growth Rate in Genital Herpes Treatment Drugs Business (2019-2024)

Figure 53. Merck & Co., Inc. Revenue Growth Rate in Genital Herpes Treatment Drugs Business (2019-2024)

Figure 54. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Genital Herpes Treatment Drugs Business (2019-2024)

Figure 55. Zydus Pharmaceuticals, Inc. Revenue Growth Rate in Genital Herpes Treatment Drugs Business (2019-2024)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions